Innovative Start-Ups at CPHI Barcelona

Feature
Article
BP ElementsBioPharm International's BP Elements, November 2023
Volume 2
Issue 11

The Start-Up Market at CPHI Barcelona brings together 27 start-ups, innovators, and small enterprises from across the pharma landscape.

As CPHI Barcelona approaches, the pharmaceutical world is gearing up to explore promising innovations that could shape the future of healthcare. This year is historic for CPHI, as it introduces a dedicated exhibition zone exclusively for start-ups, which are the innovation hubs of the industry. As part of its overarching mission to accelerate the journey of innovative medicines to patients worldwide, CPHI is shining a spotlight on some of the most promising early-stage technological innovations poised to impact the global pharmaceutical landscape. In this context, we had the privilege to engage with two emerging start-ups, one in the realm of devices and the other specializing in enhancing solubility, both offering unique solutions set to reshape the pharmaceutical landscape.

Read this article in the Trends in Formulation ebook.

About the author

This article was written by the CPHI Content Team.

Articles in this issue
Learning How to Navigate Biologics Development
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
TriLink BioTechnologies Launches Analytical Sciences Center of Excellence
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Winners of the 2023 CPHI Pharma Awards Announced
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Waters Launches New Oligonucleotide Bioanalysis Kits
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
SCHOTT Launches ViewCell Flow Cell for Biopharma Process Control
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Cellares Expands Agreement with Bristol Myers Squibb for Second CAR-T Program
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
Salipro Biotech and Icosagen to Collaborate on Antibody Discovery
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System
Innovative Start-Ups at CPHI Barcelona
Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Leroy (Lee) Hood, MD, PhD
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Rare Disease Day Celebrated on February 28

Patrick Lavery
February 28th 2025
Article

More than 6000 rare diseases—those which affect fewer than one in 2000 people each—are acknowledged in the medical community, with 72% of them being genetic.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Biotech EG 427 Raises €27 Million in Series B Funding to Advance Lead Genetic Medicine Candidate

Feliza Mirasol
February 24th 2025
Article

Co-led by Andera Partners and Bpifrance, the Series B financing will go toward an ongoing Phase Ib/IIa clinical study for EG 427’s lead candidate and to advance the company’s genetic medicines platform.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Novartis to Acquire Anthos Therapeutics with $925 Million Upfront Payment

Patrick Lavery
February 14th 2025
Article

The transaction includes abelacimab, which is a late-stage medicine that is in development for prevention of stroke and systemic embolism in patients with atrial fibrillation.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Voyager Pauses IND Filing while Assessing Alternate Payloads for SOD1 ALS Gene Therapy Program

Feliza Mirasol
February 13th 2025
Article

The company plans to assess alternate payloads for its gene therapy program, which will shift its timeline.

© 2025 MJH Life Sciences

All rights reserved.